Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Felipe B. Arcadepani & Thiago M. Fidalgo. (2023) Substance use among older adults: a review of the literature. Journal of Addictive Diseases 41:4, pages 289-299.
Read now
Read now
Leonardo J. Otuyama, Déborah Oliveira, Danilo Locatelli, Danusa de A. Machado, Ana Regina Noto, José Carlos Fernandes Galduróz, Martin J. Prince & Cleusa P. Ferri. (2020) Tobacco smoking and risk for dementia: evidence from the 10/66 population-based longitudinal study. Aging & Mental Health 24:11, pages 1796-1806.
Read now
Read now
Janine K Cataldo & Stanton A Glantz. (2010) Smoking cessation and Alzheimer’s disease: facts, fallacies and promise. Expert Review of Neurotherapeutics 10:5, pages 629-631.
Read now
Read now
Articles from other publishers (44)
Lizeth M. Zavala-Ocampo, Perla Y. López-Camacho, Eva Aguirre-Hernández, René Cárdenas-Vázquez, Herlinda Bonilla-Jaime & Gustavo Basurto-Islas. (2024) Neuroprotective effects of Petiveria alliacea on scopolamine-induced learning and memory impairment mouse model. Journal of Ethnopharmacology 318, pages 116881.
Crossref
Crossref
Michael Lardelli. (2023) An Alternative View of Familial Alzheimer’s Disease Genetics. Journal of Alzheimer's Disease 96:1, pages 13-39.
Crossref
Crossref
Ester Verdaguer, Rubén D. Castro-Torres, Jordi Olloquequi, Jesús Ureña, Miren Ettcheto, Antoni Parcerisas, Antoni Camins & Carme Auladell. 2023. Pharmacoresistance in Epilepsy. Pharmacoresistance in Epilepsy
281
308
.
Weam W. Ibrahim, Ahmed S. Kamel, Ahmed Wahid & Noha F. Abdelkader. (2022) Dapagliflozin as an autophagic enhancer via LKB1/AMPK/SIRT1 pathway in ovariectomized/d-galactose Alzheimer’s rat model. Inflammopharmacology 30:6, pages 2505-2520.
Crossref
Crossref
Joana Saavedra, Mariana Nascimento, Márcia A. Liz & Isabel Cardoso. (2022) Key brain cell interactions and contributions to the pathogenesis of Alzheimer’s disease. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Lizeth M. Zavala-Ocampo, Eva Aguirre-Hernández, Perla Y. López-Camacho, René Cárdenas-Vázquez, Alejandro Dorazco-González & Gustavo Basurto-Islas. (2022) Acetylcholinesterase inhibition and antioxidant activity properties of Petiveria alliacea L.. Journal of Ethnopharmacology 292, pages 115239.
Crossref
Crossref
Melchor Martínez-Herrera, Susana Figueroa-Gerstenmaier, Perla Y. López-Camacho, Cesar Millan-Pacheco, Miguel A. Balderas-Altamirano, Graciela Mendoza-Franco, Franciscos García-Sierra, Lizeth M. Zavala-Ocampo & Gustavo Basurto-Islas. (2022) Multiadducts of C60 Modulate Amyloid-β Fibrillation with Dual Acetylcholinesterase Inhibition and Antioxidant Properties: In Vitro and In Silico Studies. Journal of Alzheimer's Disease 87:2, pages 741-759.
Crossref
Crossref
Eunjin Sohn, Yu Jin Kim, Joo-Hwan Kim & Soo-Jin Jeong. (2021) Ficus erecta Thunb Leaves Alleviate Memory Loss Induced by Scopolamine in Mice via Regulation of Oxidative Stress and Cholinergic System. Molecular Neurobiology 58:8, pages 3665-3676.
Crossref
Crossref
Siddhartha Mondragón-Rodríguez, Humberto Salgado-Burgos & Fernando Peña-Ortega. (2020) Circuitry and Synaptic Dysfunction in Alzheimer’s Disease: A New Tau Hypothesis. Neural Plasticity 2020, pages 1-11.
Crossref
Crossref
Veronica Corsetti, Antonella Borreca, Valentina Latina, Giacomo Giacovazzo, Annabella Pignataro, Paraskevi Krashia, Francesca Natale, Sara Cocco, Marco Rinaudo, Francesca Malerba, Rita Florio, Roberta Ciarapica, Roberto Coccurello, Marcello D’Amelio, Martine Ammassari-Teule, Claudio Grassi, Pietro Calissano & Giuseppina Amadoro. (2020) Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer’s disease models. Brain Communications 2:1.
Crossref
Crossref
Donghua Zou, Rongjie Li, Xiaohua Huang, Guoying Chen, Ying Liu, Youshi Meng, Yimei Wang, Yuan Wu & Yingwei Mao. (2019) Identification of molecular correlations of RBM8A with autophagy in Alzheimer's disease. Aging 11:23, pages 11673-11685.
Crossref
Crossref
Ko, Chiou, Wong, Wang, Lai, Chou, Wang, Loh, Lieu, Cheng, Lin, Lu, Fann, Huang & Hong. (2019) GSKIP-Mediated Anchoring Increases Phosphorylation of Tau by PKA but Not by GSK3beta via cAMP/PKA/GSKIP/GSK3/Tau Axis Signaling in Cerebrospinal Fluid and iPS Cells in Alzheimer Disease. Journal of Clinical Medicine 8:10, pages 1751.
Crossref
Crossref
Verica Vasic, Kathrin Barth & Mirko H.H. Schmidt. (2019) Neurodegeneration and Neuro-Regeneration—Alzheimer’s Disease and Stem Cell Therapy. International Journal of Molecular Sciences 20:17, pages 4272.
Crossref
Crossref
Giulia Paroni, Paola Bisceglia & Davide Seripa. (2019) Understanding the Amyloid Hypothesis in Alzheimer’s Disease. Journal of Alzheimer's Disease 68:2, pages 493-510.
Crossref
Crossref
Hari Shanker Sharma, Dafin F. Muresanu, Ala Nozari, José Vicente Lafuente, Z. Ryan Tian, Asya Ozkizilcik, Igor Manzhulo, Herbert Mössler & Aruna Sharma. 2019. Nanoneuroprotection and Nanoneurotoxicology. Nanoneuroprotection and Nanoneurotoxicology
145
200
.
Akhlaq A. Farooqui. 2019. Molecular Mechanisms of Dementia. Molecular Mechanisms of Dementia
215
250
.
Daein Choi, Seulggie Choi & Sang Min Park. (2018) Effect of smoking cessation on the risk of dementia: a longitudinal study. Annals of Clinical and Translational Neurology 5:10, pages 1192-1199.
Crossref
Crossref
Tingting Li, Huahua Shi & Yan Zhao. (2018) Phosphorylation of microtubule-associated protein tau by mitogen-activated protein kinase in Alzheimer’s disease. IOP Conference Series: Materials Science and Engineering 394, pages 022023.
Crossref
Crossref
Sara Kenawy, Rehab Hegazy, Azza Hassan, Siham El-Shenawy, Nawal Gomaa, Hala Zaki & Amina Attia. (2017) Involvement of insulin resistance in D-galactose-induced age-related dementia in rats: Protective role of metformin and saxagliptin. PLOS ONE 12:8, pages e0183565.
Crossref
Crossref
Izumi Maezawa, Bende Zou, Jacopo Di Lucente, William S. Cao, Conrado Pascual, Sahani Weerasekara, Man Zhang, Xinmin Simon Xie, Duy H. Hua & Lee-Way Jin. (2017) The Anti-Amyloid-β and Neuroprotective Properties of a Novel Tricyclic Pyrone Molecule. Journal of Alzheimer's Disease 58:2, pages 559-574.
Crossref
Crossref
亦刚 陈. (2017) Abnormally Phosphorylated Tau and Tauopathies. International Journal of Psychiatry and Neurology 06:02, pages 7-12.
Crossref
Crossref
Akhlaq A. Farooqui. 2017. Neurochemical Aspects of Alzheimer's Disease. Neurochemical Aspects of Alzheimer's Disease
279
330
.
S. Mondragón-Rodríguez, G. Perry & F. Peña-Ortega. 2017. Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders. Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders
145
160
.
Tianfang Jiang, Qian Sun & Shengdi Chen. (2016) Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease. Progress in Neurobiology 147, pages 1-19.
Crossref
Crossref
Siddhartha Mondragón Rodríguez. (2016) The Use of Neuropathology in Alzheimer’s Disease. International Clinical Pathology Journal 2:5.
Crossref
Crossref
Paweł Grieb. (2015) Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer’s Disease: in Search of a Relevant Mechanism. Molecular Neurobiology 53:3, pages 1741-1752.
Crossref
Crossref
Jack C. de la TorreJack C. de la Torre. 2016. Alzheimer’s Turning Point. Alzheimer’s Turning Point
39
48
.
Joanna Wojsiat, Chiara Prandelli, Katarzyna Laskowska-Kaszub, Angeles Martín-Requero & Urszula Wojda. (2015) Oxidative Stress and Aberrant Cell Cycle in Alzheimer’s Disease Lymphocytes: Diagnostic Prospects. Journal of Alzheimer's Disease 46:2, pages 329-350.
Crossref
Crossref
Sun Ju Chung, Joanna M. Biernacka, Sebastian M. Armasu, Kari Anderson, Roberta Frigerio, Jan O. Aasly, Grazia Annesi, Anna Rita Bentivoglio, Laura Brighina, Marie-Christine Chartier-Harlin, Stefano Goldwurm, Georgios Hadjigeorgiou, Barbara Jasinska-Myga, Beom Seok Jeon, Yun Joong Kim, Rejko Krüger, Suzanne Lesage, Katerina Markopoulou, George Mellick, Karen E. Morrison, Andreas Puschmann, Eng-King Tan, David Crosiers, Jessie Theuns, Christine Van Broeckhoven, Karin Wirdefeldt, Zbigniew K. Wszolek, Alexis Elbaz & Demetrius M. Maraganore. (2014) Alpha-synuclein repeat variants and survival in Parkinson's disease. Movement Disorders 29:8, pages 1053-1057.
Crossref
Crossref
Timothy C. Durazzo, Niklas Mattsson & Michael W. Weiner. (2014) Smoking and increased Alzheimer's disease risk: A review of potential mechanisms. Alzheimer's & Dementia 10:3S.
Crossref
Crossref
S. Mondragón-Rodríguez, G. Perry, J. Luna-Muñoz, M. C. Acevedo-Aquino & S. Williams. (2014)
Phosphorylation of tau protein at sites Ser
396-404
is one of the earliest events in Alzheimer's disease and Down syndrome
. Neuropathology and Applied Neurobiology 40:2, pages 121-135.
Crossref
Crossref
Xiangfei Meng & Carl D'Arcy. (2013) Mortality and morbidity hazards associated with cognitive status in seniors: A Canadian population prospective cohort study. Asia-Pacific Psychiatry 5:3, pages 175-182.
Crossref
Crossref
Shyh-Jong Wu, Tusty-Jiuan Hsieh, Mei-Chuan Kuo, Mei-Lan Tsai, Ke-Li Tsai, Chun-Hung Chen & Yuan-Han Yang. (2013) Functional regulation of Alu element of human angiotensin-converting enzyme gene in neuron cells. Neurobiology of Aging 34:7, pages 1921.e1-1921.e7.
Crossref
Crossref
Antonio Guaita. (2013) Correlati neurobiologici nell'anziano con malattia di alzheimer e altre demenze. RICERCHE DI PSICOLOGIA:2, pages 389-406.
Crossref
Crossref
Siddhartha Mondragón-Rodríguez, George Perry, Xiongwei Zhu, Paula I. Moreira, Mariana C. Acevedo-Aquino & Sylvain Williams. (2013) Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer’s Disease. Oxidative Medicine and Cellular Longevity 2013, pages 1-6.
Crossref
Crossref
Carme Auladell, Felix Junyent, Aurelio Vazquez de la Torre, Maria Luisa de Lemos, Mercè Pallàs, Ester Verdaguer Cardona & Antoni Camins Espuny. 2013. Pharmacoresistance in Epilepsy. Pharmacoresistance in Epilepsy
99
113
.
Rachna Gupta & Lalit Kumar Gupta. (2012) Improvement in long term and visuo-spatial memory following chronic pioglitazone in mouse model of Alzheimer's disease. Pharmacology Biochemistry and Behavior 102:2, pages 184-190.
Crossref
Crossref
G. Joseph Broussard, Jennifer Mytar, Rung-chi Li & Gloria J. Klapstein. (2012) The role of inflammatory processes in Alzheimer’s disease. Inflammopharmacology 20:3, pages 109-126.
Crossref
Crossref
Peter T. Nelson, Irina Alafuzoff, Eileen H. Bigio, Constantin Bouras, Heiko Braak, Nigel J. Cairns, Rudolph J. Castellani, Barbara J. Crain, Peter Davies, Kelly Del Tredici, Charles Duyckaerts, Matthew P. Frosch, Vahram Haroutunian, Patrick R. Hof, Christine M. Hulette, Bradley T. Hyman, Takeshi Iwatsubo, Kurt A. Jellinger, Gregory A. Jicha, Enikö Kövari, Walter A. Kukull, James B. Leverenz, Seth Love, Ian R. Mackenzie, David M. Mann, Eliezer Masliah, Ann C. McKee, Thomas J. Montine, John C. Morris, Julie A. Schneider, Joshua A. Sonnen, Dietmar R. Thal, John Q. Trojanowski, Juan C. Troncoso, Thomas Wisniewski, Randall L. Woltjer & Thomas G. Beach. (2012) Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature. Journal of Neuropathology & Experimental Neurology 71:5, pages 362-381.
Crossref
Crossref
Aron S. BuchmanDavid A. Bennett. (2012) Amyloid pathology in persons with “normal” cognition. Neurology 78:4, pages 228-229.
Crossref
Crossref
Izumi Maezawa, David Paul Jenkins, Benjamin E. Jin & Heike Wulff. (2012) Microglial KCa3.1 Channels as a Potential Therapeutic Target for Alzheimer’s Disease. International Journal of Alzheimer's Disease 2012, pages 1-8.
Crossref
Crossref
Siddhartha Mondragón-Rodríguez, George Perry, Xiongwei Zhu & Jannic Boehm. (2012) Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer’s Disease Treatment: Rethinking the Current Strategy. International Journal of Alzheimer's Disease 2012, pages 1-7.
Crossref
Crossref
Siddhartha Mondragón-Rodríguez, George Perry, Xiongwei Zhu, Paula I. Moreira & Sylvain Williams. (2012) Glycogen Synthase Kinase 3: A Point of Integration in Alzheimer's Disease and a Therapeutic Target?. International Journal of Alzheimer's Disease 2012, pages 1-4.
Crossref
Crossref
Walter J. Lukiw, Jian Guo Cui, Li Yuan Yuan, Partha S. Bhattacharjee, Madelyn Corkern, Christian Clement, Eli M. Kammerman, M.J. Ball, Yuhai Zhao, Patrick M. Sullivan & James M. Hill. (2010) Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells. NeuroReport 21:14, pages 922-927.
Crossref
Crossref